BH3類似物促細胞凋亡機制及臨床研究進展
發(fā)布時間：2018-10-16 16:34
【摘要】：靶向細胞凋亡是目前癌癥治療中最具發(fā)展前景的治療方法之一。BCL-2家族的BH3-only蛋白(僅含BCL-2同源結(jié)構(gòu)域BH3)可以通過與家族中促存活蛋白結(jié)合,使促存活蛋白失效,從而使促凋亡成員發(fā)揮作用,最終導(dǎo)致細胞發(fā)生程序性凋亡。BH3類似物即一類可以模仿BH3-only蛋白并誘發(fā)細胞凋亡的小分子化合物。BH3類似物的原型ABT-737可以選擇性靶向BCL-XL、BCL-2和BCL-W 3個促存活蛋白(但不能作用于髓細胞白血病因子-1蛋白或A1蛋白),而它的衍生物ABT-263(navitoclax)在臨床試驗中有顯著的促凋亡與抗腫瘤效應(yīng)�，F(xiàn)階段,一些推測為BH3類似物的藥物已經(jīng)進入了臨床階段,但很大一部分仍在進行特征鑒定。本文在概述BH3-only蛋白作用機制的基礎(chǔ)上,綜述了多種已經(jīng)廣泛認可的BH3類似物及正在研究當中的最新BH3類似物。
[Abstract]:Targeted apoptosis is one of the most promising therapies for cancer treatment. BH3-only proteins (including only BCL-2 homologous domain BH3) of the BCL-2 family can make survivin proteins ineffective by binding to survivin in the family. In order to make apoptotic members play a role, BH3 analogue is a class of small molecular compounds that mimic BH3-only protein and induce cell apoptosis. The prototype ABT-737 of BH3 analogue can selectively target BCL-XL,BCL-2 and BCL-W three pro-survival proteins (but cannot It acts on myeloid leukemia factor-1 protein or A1 protein, and its derivative, ABT-263 (navitoclax), has significant apoptotic and anti-tumor effects in clinical trials. At this stage, some drugs that are presumed to be BH3 analogues have entered the clinical stage, but a large part of them are still in the process of characterization. On the basis of summarizing the mechanism of action of BH3-only protein, this paper reviews several widely recognized BH3 analogues and the latest BH3 analogues under study.
【作者單位】： 北京大學(xué)醫(yī)學(xué)部基礎(chǔ)醫(yī)學(xué)院藥理學(xué)系;
【基金】：國家自然科學(xué)基金(81673453);國家自然科學(xué)基金(81473235);國家自然科學(xué)基金(91129727) 教育部111項目(B07001)~~
【分類號】：R96
本文編號：2274987
[Abstract]:Targeted apoptosis is one of the most promising therapies for cancer treatment. BH3-only proteins (including only BCL-2 homologous domain BH3) of the BCL-2 family can make survivin proteins ineffective by binding to survivin in the family. In order to make apoptotic members play a role, BH3 analogue is a class of small molecular compounds that mimic BH3-only protein and induce cell apoptosis. The prototype ABT-737 of BH3 analogue can selectively target BCL-XL,BCL-2 and BCL-W three pro-survival proteins (but cannot It acts on myeloid leukemia factor-1 protein or A1 protein, and its derivative, ABT-263 (navitoclax), has significant apoptotic and anti-tumor effects in clinical trials. At this stage, some drugs that are presumed to be BH3 analogues have entered the clinical stage, but a large part of them are still in the process of characterization. On the basis of summarizing the mechanism of action of BH3-only protein, this paper reviews several widely recognized BH3 analogues and the latest BH3 analogues under study.
【作者單位】： 北京大學(xué)醫(yī)學(xué)部基礎(chǔ)醫(yī)學(xué)院藥理學(xué)系;
【基金】：國家自然科學(xué)基金(81673453);國家自然科學(xué)基金(81473235);國家自然科學(xué)基金(91129727) 教育部111項目(B07001)~~
【分類號】：R96
【相似文獻】
相關(guān)會議論文 前2條
1 宋婷;劉宇博;張志超;;磷酸化Bcl-2蛋白的BH3模擬分子——基于細胞模型的定向篩選和構(gòu)效關(guān)系研究[A];第八屆全國化學(xué)生物學(xué)學(xué)術(shù)會議論文摘要集[C];2013年
2 張志超;;一個新的BH3模擬分子——廣譜Bcl-2蛋白抑制劑[A];中國藥理學(xué)會第十次全國學(xué)術(shù)會議�？痆C];2009年
相關(guān)博士學(xué)位論文 前1條
1 劉宇博;利用小分子BH3模擬物研究磷酸化修飾對Bcl-2家族蛋白網(wǎng)絡(luò)的調(diào)控機制[D];大連理工大學(xué);2014年
相關(guān)碩士學(xué)位論文 前2條
1 盛紅坤;BH3模擬物協(xié)同紫杉醇治療慢性粒細胞白血�。–ML）的分子機制研究[D];大連理工大學(xué);2014年
2 楊洪娜;利用新苊并雜環(huán)類小分子探測Bcl-2和Mcl-1蛋白的BH3域三維尺度[D];大連理工大學(xué);2011年
，本文編號：2274987
本文鏈接：http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2274987.html
最近更新
教材專著
